SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001213900-19-023541
Filing Date
2019-11-14
Accepted
2019-11-14 17:11:59
Documents
13

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ff32019_gamidacellltd.htm F-3 663537
2 CONTROLLED EQUITY OFFERINGSM SALES AGREEMENT, DATED NOVEMBER 14, 2019, BY AND BE ff32019ex1-2_gamidacell.htm EX-1.2 252933
3 FORM OF INDENTURE BETWEEN THE REGISTRANT AND ONE OR MORE TRUSTEES TO BE NAMED ff32019ex4-3_gamidacell.htm EX-4.3 333650
4 OPINION OF MEITAR LIQUORNIK GEVA LESHEM TAL ff32019ex5-1_gamidacell.htm EX-5.1 33652
5 OPINION OF COOLEY LLP ff32019ex5-2_gamidacell.htm EX-5.2 18652
6 CONSENT OF KOST, FORER, GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL, IND ff32019ex23-1_gamidacell.htm EX-23.1 3021
7 GRAPHIC img_001.jpg GRAPHIC 4919
8 GRAPHIC img_002.jpg GRAPHIC 4041
9 GRAPHIC img_004.jpg GRAPHIC 4041
10 GRAPHIC pipeline.jpg GRAPHIC 81533
11 GRAPHIC ex5-1_001.jpg GRAPHIC 37816
12 GRAPHIC ex5-1_002.jpg GRAPHIC 4529
13 GRAPHIC ex5-2_001.jpg GRAPHIC 7991
  Complete submission text file 0001213900-19-023541.txt   1501236
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-234701 | Film No.: 191221552
SIC: 2836 Biological Products, (No Diagnostic Substances)